Cargando…
MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease
Membrane-type 5-matrix metalloproteinase (MT5-MMP) is a proteinase mainly expressed in the nervous system with emerging roles in brain pathophysiology. The implication of MT5-MMP in Alzheimer’s disease (AD), notably its interplay with the amyloidogenic process, remains elusive. Accordingly, we cross...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700096/ https://www.ncbi.nlm.nih.gov/pubmed/26202697 http://dx.doi.org/10.1007/s00018-015-1992-1 |
_version_ | 1782408274967003136 |
---|---|
author | Baranger, Kévin Marchalant, Yannick Bonnet, Amandine E. Crouzin, Nadine Carrete, Alex Paumier, Jean-Michel Py, Nathalie A. Bernard, Anne Bauer, Charlotte Charrat, Eliane Moschke, Katrin Seiki, Mothoharu Vignes, Michel Lichtenthaler, Stefan F. Checler, Frédéric Khrestchatisky, Michel Rivera, Santiago |
author_facet | Baranger, Kévin Marchalant, Yannick Bonnet, Amandine E. Crouzin, Nadine Carrete, Alex Paumier, Jean-Michel Py, Nathalie A. Bernard, Anne Bauer, Charlotte Charrat, Eliane Moschke, Katrin Seiki, Mothoharu Vignes, Michel Lichtenthaler, Stefan F. Checler, Frédéric Khrestchatisky, Michel Rivera, Santiago |
author_sort | Baranger, Kévin |
collection | PubMed |
description | Membrane-type 5-matrix metalloproteinase (MT5-MMP) is a proteinase mainly expressed in the nervous system with emerging roles in brain pathophysiology. The implication of MT5-MMP in Alzheimer’s disease (AD), notably its interplay with the amyloidogenic process, remains elusive. Accordingly, we crossed the genetically engineered 5xFAD mouse model of AD with MT5-MMP-deficient mice and examined the impact of MT5-MMP deficiency in bigenic 5xFAD/MT5-MMP(−/−) mice. At early stages (4 months) of the pathology, the levels of amyloid beta peptide (Aβ) and its amyloid precursor protein (APP) C-terminal fragment C99 were largely reduced in the cortex and hippocampus of 5xFAD/MT5-MMP(−/−), compared to 5xFAD mice. Reduced amyloidosis in bigenic mice was concomitant with decreased glial reactivity and interleukin-1β (IL-1β) levels, and the preservation of long-term potentiation (LTP) and spatial learning, without changes in the activity of α-, β- and γ-secretases. The positive impact of MT5-MMP deficiency was still noticeable at 16 months of age, as illustrated by reduced amyloid burden and gliosis, and a better preservation of the cortical neuronal network and synaptophysin levels in bigenic mice. MT5-MMP expressed in HEKswe cells colocalized and co-immunoprecipitated with APP and significantly increased the levels of Aβ and C99. MT5-MMP also promoted the release of a soluble APP fragment of 95 kDa (sAPP95) in HEKswe cells. sAPP95 levels were significantly reduced in brain homogenates of 5xFAD/MT5-MMP(−/−) mice, supporting altogether the idea that MT5-MMP influences APP processing. MT5-MMP emerges as a new pro-amyloidogenic regulator of APP metabolism, whose deficiency alleviates amyloid pathology, neuroinflammation and cognitive decline. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00018-015-1992-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4700096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-47000962016-01-11 MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease Baranger, Kévin Marchalant, Yannick Bonnet, Amandine E. Crouzin, Nadine Carrete, Alex Paumier, Jean-Michel Py, Nathalie A. Bernard, Anne Bauer, Charlotte Charrat, Eliane Moschke, Katrin Seiki, Mothoharu Vignes, Michel Lichtenthaler, Stefan F. Checler, Frédéric Khrestchatisky, Michel Rivera, Santiago Cell Mol Life Sci Research Article Membrane-type 5-matrix metalloproteinase (MT5-MMP) is a proteinase mainly expressed in the nervous system with emerging roles in brain pathophysiology. The implication of MT5-MMP in Alzheimer’s disease (AD), notably its interplay with the amyloidogenic process, remains elusive. Accordingly, we crossed the genetically engineered 5xFAD mouse model of AD with MT5-MMP-deficient mice and examined the impact of MT5-MMP deficiency in bigenic 5xFAD/MT5-MMP(−/−) mice. At early stages (4 months) of the pathology, the levels of amyloid beta peptide (Aβ) and its amyloid precursor protein (APP) C-terminal fragment C99 were largely reduced in the cortex and hippocampus of 5xFAD/MT5-MMP(−/−), compared to 5xFAD mice. Reduced amyloidosis in bigenic mice was concomitant with decreased glial reactivity and interleukin-1β (IL-1β) levels, and the preservation of long-term potentiation (LTP) and spatial learning, without changes in the activity of α-, β- and γ-secretases. The positive impact of MT5-MMP deficiency was still noticeable at 16 months of age, as illustrated by reduced amyloid burden and gliosis, and a better preservation of the cortical neuronal network and synaptophysin levels in bigenic mice. MT5-MMP expressed in HEKswe cells colocalized and co-immunoprecipitated with APP and significantly increased the levels of Aβ and C99. MT5-MMP also promoted the release of a soluble APP fragment of 95 kDa (sAPP95) in HEKswe cells. sAPP95 levels were significantly reduced in brain homogenates of 5xFAD/MT5-MMP(−/−) mice, supporting altogether the idea that MT5-MMP influences APP processing. MT5-MMP emerges as a new pro-amyloidogenic regulator of APP metabolism, whose deficiency alleviates amyloid pathology, neuroinflammation and cognitive decline. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00018-015-1992-1) contains supplementary material, which is available to authorized users. Springer International Publishing 2015-07-23 2016 /pmc/articles/PMC4700096/ /pubmed/26202697 http://dx.doi.org/10.1007/s00018-015-1992-1 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Article Baranger, Kévin Marchalant, Yannick Bonnet, Amandine E. Crouzin, Nadine Carrete, Alex Paumier, Jean-Michel Py, Nathalie A. Bernard, Anne Bauer, Charlotte Charrat, Eliane Moschke, Katrin Seiki, Mothoharu Vignes, Michel Lichtenthaler, Stefan F. Checler, Frédéric Khrestchatisky, Michel Rivera, Santiago MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease |
title | MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease |
title_full | MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease |
title_fullStr | MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease |
title_full_unstemmed | MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease |
title_short | MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease |
title_sort | mt5-mmp is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of alzheimer’s disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700096/ https://www.ncbi.nlm.nih.gov/pubmed/26202697 http://dx.doi.org/10.1007/s00018-015-1992-1 |
work_keys_str_mv | AT barangerkevin mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT marchalantyannick mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT bonnetamandinee mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT crouzinnadine mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT carretealex mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT paumierjeanmichel mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT pynathaliea mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT bernardanne mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT bauercharlotte mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT charrateliane mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT moschkekatrin mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT seikimothoharu mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT vignesmichel mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT lichtenthalerstefanf mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT checlerfrederic mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT khrestchatiskymichel mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease AT riverasantiago mt5mmpisanewproamyloidogenicproteinasethatpromotesamyloidpathologyandcognitivedeclineinatransgenicmousemodelofalzheimersdisease |